Evogene's total assets for Q2 2026 were $13.44M, a decrease of -25.12% from the previous quarter. EVGN total liabilities were $7.67M for the fiscal quarter, a -22.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.